September 29th 2025
In this continuation of a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.
Impacts of Process Analytical Technology
November 9th 2005The process analytical technology (PAT) initiative has been percolating at the US Food and Drug Administration for a long time, explained FDA's John E. Simmons at the AAPS Annual Meeting and Exposition on Wednesday. "If you think of PAT as an isolated set of applications, I think you are missing the point," Simmons said. "The FDA would like PAT to become commonplace?not to be an initiative, but common practice."
Improving Process Control and Analytical Methods for Bioprocesses
November 8th 2005"The better we understand the relationship between process parameters and product attributes, the better control we'll have over product quality," said Beth Fowler, PhD, during Tuesday?s session on process monitoring at the AAPS Annual Meeting.
Validation and Compliance: Software Systems Prepare Manufacturers for Com(PAT)ibility
May 2nd 2004From data acquisition to enterprise resource planning, software systems operating at all levels of pharmaceutical manufacturing prepare for the seemingly inevitable implementation of process anlytical technology.